VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 103 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $784,732 | +26.4% | 101,781 | 0.0% | 0.02% | +31.2% |
| Q4 2022 | $620,864 | +3.0% | 101,781 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $603,000 | +17.5% | 101,781 | +17.3% | 0.02% | +33.3% |
| Q2 2022 | $513,000 | -22.4% | 86,781 | 0.0% | 0.01% | -7.7% |
| Q1 2022 | $661,000 | +561.0% | 86,781 | +135.9% | 0.01% | +550.0% |
| Q4 2021 | $100,000 | -79.1% | 36,781 | -79.8% | 0.00% | -77.8% |
| Q3 2021 | $478,000 | -26.0% | 181,881 | +16.4% | 0.01% | -25.0% |
| Q2 2021 | $646,000 | -48.1% | 156,300 | -40.9% | 0.01% | -47.8% |
| Q1 2021 | $1,245,000 | +88.1% | 264,339 | +655.3% | 0.02% | +283.3% |
| Q3 2018 | $662,000 | -51.6% | 35,000 | -50.0% | 0.01% | -57.1% |
| Q2 2018 | $1,368,000 | +4.0% | 70,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,315,000 | +13.2% | 70,000 | 0.0% | 0.01% | +7.7% |
| Q4 2017 | $1,162,000 | -19.4% | 70,000 | 0.0% | 0.01% | -18.8% |
| Q3 2017 | $1,441,000 | – | 70,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |